Angiotensin in Critical Care

Anna Hall, Laurence W Busse, Marlies Ostermann, Anna Hall, Laurence W Busse, Marlies Ostermann

Abstract

This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2018. Other selected articles can be found online at https://www.biomedcentral.com/collections/annualupdate2018 . Further information about the Annual Update in Intensive Care and Emergency Medicine is available from http://www.springer.com/series/8901 .

Conflict of interest statement

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
The renin-angiotensin system. ACE: angiotensin-converting enzyme; ACTH: adrenocorticotropin hormone; AT: angiotensin receptor

References

    1. Walsh M, Devereaux PJ, Garg AX, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013;119:507–515. doi: 10.1097/ALN.0b013e3182a10e26.
    1. Salmasi V, Maheshwari K, Yang D, et al. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery. Anesthesiology. 2017;126:47–65. doi: 10.1097/ALN.0000000000001432.
    1. Cecconi M, De Backer D, Antonelli M, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40:1795–1815. doi: 10.1007/s00134-014-3525-z.
    1. Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304–377. doi: 10.1007/s00134-017-4683-6.
    1. Sakr Y, Reinhart K, Vincent J-L, et al. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med. 2006;34:589–597. doi: 10.1097/01.CCM.0000201896.45809.E3.
    1. Myburgh JA, Higgins A, Jovanovska A, et al. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med. 2008;34:2226–2234. doi: 10.1007/s00134-008-1219-0.
    1. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877–887. doi: 10.1056/NEJMoa067373.
    1. Zhou F, Mao Z, Zeng X, et al. Vasopressors in septic shock: a systematic review and network meta-analysis. Ther Clin Risk Manag. 2015;11:1047–1059. doi: 10.2147/TCRM.S80060.
    1. Khanna A, English SW, Wang XS, et al. Angiotensin II for the treatment of vasodilatory shock. N Engl J Med. 2017;377:419–430. doi: 10.1056/NEJMoa1704154.
    1. Chawla LS, Busse L, Brasha-Mitchell E, et al. Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study. Crit Care. 2014;18:534. doi: 10.1186/s13054-014-0534-9.
    1. Correa TD, Takala J, Jakob SM. Angiotensin II in septic shock. Crit Care. 2015;19:98. doi: 10.1186/s13054-015-0802-3.
    1. Tigerstedt R, Bergman P. Niere und Kreislauf. Scand Arch Physiol. 1898;8:223–271. doi: 10.1111/j.1748-1716.1898.tb00272.x.
    1. Correa TD, Takala J, Jakob S. Angiotensin II in septic shock. Crit Care. 2015;19:98. doi: 10.1186/s13054-015-0802-3.
    1. Paul M, Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev. 2006;86:747–803. doi: 10.1152/physrev.00036.2005.
    1. Kopf P, Campbell W. Endothelial metabolism of angiotensin II to angiotensin III, not angiotensin (1–7), augments the vasorelaxation response in adrenal cortical arteries. Endocrinology. 2013;154:4768–4776. doi: 10.1210/en.2013-1160.
    1. Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Intern Med. 2008;264:224–236. doi: 10.1111/j.1365-2796.2008.01981.x.
    1. Steckelings UM, Kaschina E, Unger T. The AT2 receptor – a matter of love and hate. Peptides. 2005;26:1401–1419. doi: 10.1016/j.peptides.2005.03.010.
    1. Bucher M, Hobbhahn J, Kurtz A. Nitric oxide-dependent down-regulation of angiotensin II type 2 receptors during experimental sepsis. Crit Care Med. 2001;29:1750–1755. doi: 10.1097/00003246-200109000-00016.
    1. Carey RM, Wang ZQ, Siragy HM. Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function. Hypertension. 2000;35:155–163. doi: 10.1161/01.HYP.35.1.155.
    1. Zhang W, Chen X, Huang L, et al. Severe sepsis: Low expression of the renin-angiotensin system is associated with poor prognosis. Exp Ther Med. 2014;7:1342–1348. doi: 10.3892/etm.2014.1566.
    1. Dong LW, Chang YZ, Tong LJ, Tang J, Su JY, Tang CS. Role of regulatory peptide in pathogenesis of shock. Sci China B. 1994;37:162–169.
    1. Dunn CW, Horton JW. Role of angiotensin II in neonatal sepsis. Circ Shock. 1993;40:144–150.
    1. Chawla LS, Busse LW, Brasha-Mitchell E, Alotaibi Z. The use of angiotensin II in distributive shock. Crit Care. 2016;20:13. doi: 10.1186/s13054-016-1306-5.
    1. Wray GM, Coakley JH. Severe septic shock unresponsive to noradrenaline. Lancet. 1995;346:1604. doi: 10.1016/S0140-6736(95)91933-3.
    1. Salgado DR, Rocco JR, Silva E, Vincent J-L. Modulation of the renin-angiotensin-aldosterone system in sepsis: a new therapeutic approach? Expert Opin Ther Targets. 2010;14:11–20. doi: 10.1517/14728220903460332.
    1. Orfanos SE, Langleben D, Khoury J, et al. Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in humans. Circulation. 1999;99:1593–1599. doi: 10.1161/01.CIR.99.12.1593.
    1. Orfanos SE, Armaganidis A, Glynos C, et al. Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury. Circulation. 2000;102:2011–2018. doi: 10.1161/01.CIR.102.16.2011.
    1. Casey L, Krieger B, Kohler J, Rice C, Oparil S, Szidon P. Decreased serum angiotensin converting enzyme in adult respiratory distress syndrome associated with sepsis: a preliminary report. Crit Care Med. 1981;9:651–654. doi: 10.1097/00003246-198109000-00008.
    1. Johnson AR, Coalson JJ, Ashton J, Larumbide M, Erdös EG. Neutral endopeptidase in serum samples from patients with adult respiratory distress syndrome. Comparison with angiotensin-converting enzyme. Am Rev Respir Dis. 1985;132:1262–1267.
    1. Kuba K, Imai Y, Penninger JM. Angiotensin-converting enzyme 2 in lung disease. Curr Opin Pharmacol. 2006;6:271–276. doi: 10.1016/j.coph.2006.03.001.
    1. Bucher M, Ittner KP, Hobbhahn J, Taeger K, Kurtz A. Downregulation of angiotensin II type 1 receptors during sepsis. Hypertension. 2001;38:177–182. doi: 10.1161/01.HYP.38.2.177.
    1. Schmidt C, Höcherl K, Kurt B, Moritz S, Kurtz A, Bucher M. Blockade of multiple but not single cytokines abrogates downregulation of angiotensin II type-I receptors and anticipates septic shock. Cytokine. 2010;49:30–38. doi: 10.1016/j.cyto.2009.10.006.
    1. Mederle K, Schweda F, Kattler V, et al. The angiotensin II AT1 receptor-associated protein Arap1 is involved in sepsis-induced hypotension. Crit Care. 2013;17:R130. doi: 10.1186/cc12809.
    1. Busse LW, Wang XS, Chalikonda DM, et al. Clinical experience with IV angiotensin ii administration: a systematic review of safety. Crit Care Med. 2017;45:1285–1294. doi: 10.1097/CCM.0000000000002441.
    1. Chooi C, Cox JJ, Lumb RS et al (2017) Techniques for preventing hypotension during spinal anaesthesia for caesarean section. Cochrane Database Syst Rev CD002251.
    1. McGrath J, Chestnut D, Vincent R, et al. Ephedrine remains the vasopressor of choice for treatment of hypotension during ritodrine infusion and epidural anesthesia. Anesthesiology. 1994;80:1073–1081. doi: 10.1097/00000542-199405000-00016.
    1. Shearer VE, Ramin SM, Wallace DH, Dax JS, Gilstrap LC., 3rd Fetal effects of prophylactic ephedrine and maternal hypotension during regional anesthesia for cesarean section. J Matern Fetal Med. 1996;5:79–84. doi: 10.1002/(SICI)1520-6661(199603/04)5:2<79::AID-MFM6>;2-N.
    1. Naden RP, Rosenfeld CR. Effect of angiotensin II on uterine and systemic vasculature in pregnant sheep. J Clin Invest. 1981;68:468–474. doi: 10.1172/JCI110277.
    1. Rosenfeld CR, Naden RP. Uterine and nonuterine vascular responses to angiotensin II in ovine pregnancy. Am J Physiol. 1989;257:H17–H24.
    1. Ramin SM, Ramin KD, Cox K, Magness RR, Shearer VE, Gant NF. Comparison of prophylactic angiotensin II versus ephedrine infusion for prevention of maternal hypotension during spinal anesthesia. Am J Obstet Gynecol. 1994;171:734–739. doi: 10.1016/0002-9378(94)90090-6.
    1. Vincent RD, Jr, Werhan CF, Norman PF, et al. Prophylactic angiotensin II infusion during spinal anesthesia for elective cesarean delivery. Anesthesiology. 1998;88:1475–1479. doi: 10.1097/00000542-199806000-00009.
    1. Jackson T, Corke C, Agar J. Enalapril overdose treated with angiotensin infusion. Lancet. 1993;341:703. doi: 10.1016/0140-6736(93)90479-Z.
    1. Newby DE, Lee MR, Gray AJ, Boon NA. Enalapril overdose and the corrective effect of intravenous angiotensin II. Br J Clin Pharmacol. 1995;40:103–104. doi: 10.1111/j.1365-2125.1995.tb04546.x.
    1. Trilli LE, Johnson KA. Lisinopril overdose and management with intravenous angiotensin II. Ann Pharmacother. 1994;28:1165–1167. doi: 10.1177/106002809402801006.
    1. Brand DA, Patrick PA, Berger JT, et al. Intensity of vasopressor therapy for septic shock and the risk of in-hospital death. J Pain Symptom Manage. 2017;53:938–943. doi: 10.1016/j.jpainsymman.2016.12.333.
    1. John JN, Luria MH. Studies in clinical shock and hypotension. II. Hemodynamic effects of norepinephrine and angiotensin. J Clin Invest. 1965;44:1494–1504. doi: 10.1172/JCI105256.
    1. Belle MS, Jaffee RJ. The use of large doses of angiotensin in acute myocardial infarction with shock. J Lancet. 1965;85:193–194.
    1. Busse LW, McCurdy MT, Osman A, Hall A, Chen H, Ostermann M. The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature. Crit Care. 2017;21:34. doi: 10.1186/s13054-017-1896-6.
    1. Bellomo R, Hilton A. The ATHOS-3 trial, angiotensin II and The Three Musketeers. Crit Care Resusc. 2017;19:3–4.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться